You are here: Industry Insights > side effects

News List

Class 4 Medicines Defect: missing safety information in some Perindopril products europeanpharmaceuticalreview
December 17, 2020
The MHRA reports that certain packs of Perindopril products are missing important safety information, the products are not being recalled.
EMA warns about side effects of chloroquine and hydroxychloroquine for COVID-19 treatment europeanpharmaceuticalreview
April 24, 2020
The COVID-19 European Medicines Agency (EMA) pandemic Task Force (COVID-ETF) warned that chloroquine and hydroxychloroquine are yet to be proved effective at treating COVID-19 and that their side effects could be fatal.
Side Effects Seen With Use of Chloroquine Against COVID-19 Drugs.com
April 08, 2020
The use of the antimalarial drug chloroquine to treat COVID-19 patients has been halted at several Swedish hospitals due to reported side effects such as cramps and loss of peripheral vision.
New opioid with faster results and less side effects developed pharmaceutical-technology
May 23, 2019
Researchers at Tulane University, US, have developed a new opioid that works quicker than morphine and other opioid painkillers, and does not produce the same pain sensitivity and addiction.
FDA clears GSK's Dovato, first 2-drug regimen for new HIV adults fiercepharma
April 10, 2019
In a landmark win for GlaxoSmithKline’s ViiV Healthcare and its ambition to reduce the number of medications HIV patients are taking—and...
UK researchers devise new radiotherapy plan to reduce side effects pharmaceutical-technology
February 20, 2019
Physicists at The Institute of Cancer Research (ICR) and The Royal Marsden NHS Foundation Trust have devised a new treatment plan to avoid the impact of radiotherapy on sensitive organs near tumours and reduce associated side effects.....
UC Berkeley develops drug sponge to soak up chemotherapy side effects pharmaceutical-technology
January 11, 2019
Chemical engineers at the University of California, Berkeley (UC Berkeley) have developed a drug sponge that could absorb the residual chemotherapy drug and minimise cancer treatment side effects.....
J&J stock tumbles after Reuters reports it hid asbestos in talc fiercepharma
January 02, 2019
After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters reported the drugmaker knew for decades its talc powder contained cancer-causing asbestos.
New clinical trial reduces breast cancer radiotherapy side effects pharmatimes
December 24, 2018
A practice-changing new clinical trial has been found to reduce long-term radiotherapy side effects in women with breast cancer.
J&J stock tumbles after Reuters report on asbestos in talc fiercepharma
December 19, 2018
After a series of ups and downs in defense of its flagship Johnson’s Baby Powder, Johnson & Johnson hit renewed scrutiny Friday as Reuters reported the drugmaker knew for decades its talc powder contained cancer-causing asbestos.

Previous page 1 2 Next page